Does Hormone Replacement Therapy Impact the Prognosis in Endometrial Cancer Survivors? A Systematic Review
Author(s) -
Violante Di Donato,
Innocenza Palaia,
Debora D’Aniello,
Lucia Musacchio,
Giusi Santangelo,
Federica Mauro,
Anna Di Pinto,
Angela Musella,
Margherita Fischetti,
Federica Tomao,
Giorgia Perniola,
Pierluigi Benedetti Panici
Publication year - 2020
Publication title -
oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.987
H-Index - 98
eISSN - 1423-0232
pISSN - 0030-2414
DOI - 10.1159/000505427
Subject(s) - medicine , endometrial cancer , cochrane library , hormone replacement therapy (female to male) , randomized controlled trial , medline , population , cancer , gynecology , hormone therapy , stage (stratigraphy) , oncology , breast cancer , environmental health , political science , law , testosterone (patch) , paleontology , biology
The objective of this study was to evaluate the impact of hormone replacement therapy (HRT) on the prognosis in endometrial cancer (EC) survivors.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom